These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 27017984)

  • 61. A Pan-ALDH1A Inhibitor Induces Necroptosis in Ovarian Cancer Stem-like Cells.
    Chefetz I; Grimley E; Yang K; Hong L; Vinogradova EV; Suciu R; Kovalenko I; Karnak D; Morgan CA; Chtcherbinine M; Buchman C; Huddle B; Barraza S; Morgan M; Bernstein KA; Yoon E; Lombard DB; Bild A; Mehta G; Romero I; Chiang CY; Landen C; Cravatt B; Hurley TD; Larsen SD; Buckanovich RJ
    Cell Rep; 2019 Mar; 26(11):3061-3075.e6. PubMed ID: 30865894
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 63. PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling.
    Klutzny S; Anurin A; Nicke B; Regan JL; Lange M; Schulze L; Parczyk K; Steigemann P
    Cell Death Dis; 2018 Feb; 9(2):192. PubMed ID: 29416006
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation.
    Guo F; Yang Z; Kulbe H; Albers AE; Sehouli J; Kaufmann AM
    Biomed Pharmacother; 2019 Oct; 118():109371. PubMed ID: 31545281
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden.
    van der Zee M; Sacchetti A; Cansoy M; Joosten R; Teeuwssen M; Heijmans-Antonissen C; Ewing-Graham PC; Burger CW; Blok LJ; Fodde R
    Cancer Res; 2015 Sep; 75(17):3608-22. PubMed ID: 26130650
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ALDH activity indicates increased tumorigenic cells, but not cancer stem cells, in prostate cancer cell lines.
    Yu C; Yao Z; Dai J; Zhang H; Escara-Wilke J; Zhang X; Keller ET
    In Vivo; 2011; 25(1):69-76. PubMed ID: 21282737
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3.
    Ma L; Lai D; Liu T; Cheng W; Guo L
    Acta Biochim Biophys Sin (Shanghai); 2010 Sep; 42(9):593-602. PubMed ID: 20705681
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of the immunogenicity of ALDH(high) human head and neck squamous cell carcinoma cancer stem cells in vitro.
    Prince MEP; Zhou L; Moyer JS; Tao H; Lu L; Owen J; Etigen M; Zheng F; Chang AE; Xia J; Wolf G; Wicha MS; Huang S; Ren X; Li Q
    Oral Oncol; 2016 Aug; 59():30-42. PubMed ID: 27424180
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere cultures.
    Saw YT; Yang J; Ng SK; Liu S; Singh S; Singh M; Welch WR; Tsuda H; Fong WP; Thompson D; Vasiliou V; Berkowitz RS; Ng SW
    BMC Cancer; 2012 Aug; 12():329. PubMed ID: 22852552
    [TBL] [Abstract][Full Text] [Related]  

  • 70. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
    Farnie G; Sotgia F; Lisanti MP
    Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preventive cancer stem cell-based vaccination reduces liver metastasis development in a rat colon carcinoma syngeneic model.
    Duarte S; Momier D; Baqué P; Casanova V; Loubat A; Samson M; Guigonis JM; Staccini P; Saint-Paul MC; De Lima MP; Carle GF; Pierrefite-Carle V
    Stem Cells; 2013 Mar; 31(3):423-32. PubMed ID: 23193035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.
    Hu Z; Xu J; Cheng J; McMichael E; Yu L; Carson WE
    Oncotarget; 2017 Jan; 8(1):1481-1494. PubMed ID: 27903969
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2.
    Choi YJ; Ingram PN; Yang K; Coffman L; Iyengar M; Bai S; Thomas DG; Yoon E; Buckanovich RJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):E6882-8. PubMed ID: 26621735
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Flow cytometric analysis for detection of tumor-initiating cells in feline mammary carcinoma cell lines.
    Michishita M; Otsuka A; Nakahira R; Nakagawa T; Sasaki N; Arai T; Takahashi K
    Vet Immunol Immunopathol; 2013 Nov; 156(1-2):73-81. PubMed ID: 24041801
    [TBL] [Abstract][Full Text] [Related]  

  • 75. SNAIL induces epithelial-to-mesenchymal transition and cancer stem cell-like properties in aldehyde dehydroghenase-negative thyroid cancer cells.
    Yasui K; Shimamura M; Mitsutake N; Nagayama Y
    Thyroid; 2013 Aug; 23(8):989-96. PubMed ID: 23432420
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.
    Liu SY; Zheng PS
    Oncotarget; 2013 Dec; 4(12):2462-75. PubMed ID: 24318570
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs.
    Puvanenthiran S; Essapen S; Seddon AM; Modjtahedi H
    Int J Oncol; 2016 Nov; 49(5):1825-1838. PubMed ID: 27599579
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
    Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells.
    Whitworth JM; Londoño-Joshi AI; Sellers JC; Oliver PJ; Muccio DD; Atigadda VR; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2012 Apr; 125(1):226-30. PubMed ID: 22155260
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ovarian cancer stem cells: working towards the root of stemness.
    Foster R; Buckanovich RJ; Rueda BR
    Cancer Lett; 2013 Sep; 338(1):147-57. PubMed ID: 23138176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.